Ballast Advisors LLC raised its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 1.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,751 shares of the conglomerate’s stock after buying an additional 50 shares during the quarter. Ballast Advisors LLC’s holdings in Danaher were worth $1,043,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher in the 2nd quarter worth $25,000. nVerses Capital LLC acquired a new stake in Danaher during the second quarter worth about $25,000. MFA Wealth Advisors LLC bought a new position in Danaher during the second quarter valued at about $51,000. Financial Connections Group Inc. acquired a new position in Danaher in the 2nd quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in shares of Danaher during the 1st quarter worth approximately $55,000. 79.05% of the stock is owned by institutional investors.
Insider Transactions at Danaher
In related news, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 10.90% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Get Our Latest Stock Report on DHR
Danaher Stock Performance
Danaher stock opened at $248.66 on Wednesday. Danaher Co. has a 12-month low of $192.35 and a 12-month high of $281.70. The stock has a 50-day simple moving average of $266.16 and a 200 day simple moving average of $260.84. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $179.60 billion, a price-to-earnings ratio of 47.74, a P/E/G ratio of 4.55 and a beta of 0.85.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company’s revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the firm posted $2.02 earnings per share. On average, research analysts anticipate that Danaher Co. will post 7.51 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.43%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Dividend Payout Ratio Calculator
- 3 Rising-Margin Stocks with Strong Growth Potential
- Insider Buying Explained: What Investors Need to Know
- 3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt
- How to Use the MarketBeat Dividend Calculator
- 2 Alternative Internet Stocks Staging a Breakout in 2024
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.